Search

everythinglearnresearchcommunity

for

Search:↓

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Treating Netherton syndrome with growth hormone and dupilumab improves growth safely.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

Low-level laser therapy effectively treats hair loss, especially when combined with finasteride.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Emulgel improves skin delivery of various drugs better than traditional methods.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

PRP is an effective and safe treatment for alopecia areata.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Injectable ACell with blood serum/PRP may slow hair loss and regrow thinning hair.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

The hydrogel improves hair growth treatment by enhancing drug delivery and promoting follicle repair.

Microneedles can precisely deliver cancer treatments with fewer side effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

The minoxidil gel is stable and effective for treating alopecia areata.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Combining PRP with LLLT is most effective for hair growth in androgenetic alopecia.

Latanoprost's effectiveness for hair growth is not confirmed but shows promise, needing more research.